Return to Medical Topics Home Page

LIPOPROTEIN(a):  THE UGLY CHOLESTEROL

 1.  Lipoprotein(a):  What is it and what is its role in health?

        Lipoprotein(a), abbreviated as Lp(a), is composed of one molecule of LDL, the bad cholesterol, chemically bound to a carrier protein called apolipoprotein(a).  Lp(a) is an adhesive particle, and in health serves to repair and restore the structural integrity of a damaged blood vessel wall -a sort of biological super glue.  It’s apolipoprotein(a) component promotes blood clotting and inhibits your body’s blood clot dissolving system.  This is Mother Nature’s mechanism to prevent excessive blood loss from a damaged vessel.  Lp(a) also promotes vessel wall cellular growth and proliferation, and its LDL cholesterol is incorporated into the regenerating cells.  Essentially, Lipoprotein(a) is a repair molecule, an “artery patch”.

      Vitamin C can also serve to maintain or restore the wall strength of our blood vessels, rendering Lp(a) unnecessary,  A dog the size of an average man will convert dietary sugar (glucose) into 20,000 mgs. of Vitamin C each day.  We will see that this is nature’s preferred approach.  Man, the great apes, guinea pigs, and hedgehogs lost the ability to make Vitamin C from sugar, and rely on Lp(a) instead to keep their arteries intact.  Man and these other species do develop coronary artery disease.  All other animals make Vitamin C; Lp(a) is not found in their blood, and these animals never develop coronary disease.  These Vitamin C producers do not obstruct their blood vessels with cholesterol and blood clots!  

     During the Ice Age, agriculture ground to a halt and natural fruits and vegetables were in short supply.  Animals that could manufacture their own Vitamin C could handle this, but mankind began to die off from blood loss anemia.  Without Vitamin C, we developed chronic scurvy; blood leaked out from our damaged arteries and we had no way to repair our vessels or to stop the bleeding.  Evolution than provided mankind with a solution.  A genetic mutation of plasminogen, the circulating protein that promotes blood clot dissolution, created apolipoprotein(a), a plasminogen look alike that does just the opposite, promoting blood clot formation and antagonizing plasminogen mediated clot dissolving.  Apo(a) plugged the hole in the dike.  Combined with LDL to form Lp(a), it restored the strength of our vessels.  Individuals who couldn’t make Lp(a) died; those who could make Lp(a) survived the Ice Age and passed on  their Lp(a) producing genes to their descendants.  This is why some Lp(a) is present in all of us.  Lp(a) obviously saved mankind from extinction during the Ice Age, but what is this cholesterol/clot producing patch system doing to us now?  

2.  The role of Lp(a) in vascular disease.

        After the Ice Age, dietary Vitamin C became plentiful again, our vessels were strong, and Lp(a) vascular “repair” was not needed. Our Vitamin C intake was at “animal” levels and mankind did not experience coronary disease.  With the advent of modern day food processing, we are again becoming Vitamin C deficient, and in our current “diet induced Ice Age”, we are again calling upon Lp(a) to patch up and repair our arteries, and today we call that patching system ATHEROSCLEROSIS.

        Lp(a) levels are under hereditary control; if your level is high, that is because your ancestors needed more to get them through the Ice Age.  The higher your level, the greater is your risk.  Lp(a) binds to lysine and proline within the wall of a damaged or weakened artery, depositing its LDL and promoting the deposition of circulating, oxidized LDL into the artery’s wall, narrowing the artery.  Lp(a) promotes the formation of blood clots on top of the cholesterol plaque, abruptly narrowing the artery further, bringing on or worsening your symptoms. If the clot is large enough, it will occlude the artery, producing a heart attack.  We now know that most heart attacks are due to a large blood clot developing in vessels with moderate narrowings (therefore you are still at risk with a 50% narrowing). 

     Lp(a) levels typically range from 1 to 100; the highest level so far in our practice has been 200.  Mg. for mg, Lp(a) has 10 times the plaque producing potential of LDL.  The average American value is 14: 13 in healthy individuals and 19 in coronary patients.  Lp(a) selectively accumulates in your arteries; a level above 30 doubles your risk, and if your LDL is also elevated, your risk rises by a factor of 5.  Lp(a) also concentrates in the walls of your bypass grafts; 90% of individuals whose bypass grafts clog up have Lp(a) levels above 31.  Balloon angioplasty (PTCA) is basically a  controlled trauma to the vascular wall, and Lp(a), always a “repair” molecule, will concentrate at the site of balloon dilation, promoting clot formation and cholesterol deposition.  You certainly won’t be surprised to learn that Lp(a) has been implicated as a cause of restenosis, renarrowing of the blood vessel following angioplasty. In one study, the Lp(a) level averaged 7 in patients who did not renarrow, and 19 in those who did.  Those patients with a level above 40 were 11 times more likely to restenose than those with levels below 4.  Those with levels above 19 were 6 times as likely to renarrow.  

3.  What can I do to lower my Lp(a) related coronary risk?  Plenty:  

A.  Have your Lp(a) level measured (along with your other risk factors).

B.  If your level is elevated, work with your doctor to lower it with Niacin and Vitamin C - not the 60 mgs. of Vitamin C present in a one-a-day but by “healthy animal” doses in the 5-10,000 mgs. per day range.  Unfortunately, Lp(a) is not effected by exercise, dietary modification, or our standard cholesterol lowering drugs.

C.  The Lp(a) that cannot be lowered can be neutralized by supplemental Lysine and Proline.  By occupying the binding sites on the circulating Lp(a) particle, Lysine and Proline prevent Lp(a) from attaching to Lysine and Proline within the vascular wall, and if the Lp(a) cannot attach, it cannot promote cholesterol deposition and blood clotting within the coronary artery.  In optimal doses, Lysine and Proline may be able to insinuate themselves between bound Lp(a) and the vascular wall, freeing up Lp(a) and pulling it out of the vascular wall. The now freed-up Lp(a) will take cholesterol out with it, lessening the degree of vessel narrowing.  Many of my patients take Heart Technology™, a preparation designed specifically for Lp(a) control.  Heart Technology™contains measured amounts of Lysine, Proline, Vitamin C, and several other agents with vasoprotective qualities.

D.  To learn more, please attend our next “The Ugly Cholesterol - Lipoprotein (a) and Vitamin C” talk.  Eradicating Heart Disease and Why Animals Don’t Get Heart Attacks, by Mathias Rath MD, are easy to read booklets that also cover this material.

The Vitamin C and Pycnogenol pages also provide information related to Lipoprotein(a)                James C. Roberts MD FACC